ArticleProstate cancer2020

Somatic Mitochondrial DNA Point Mutations Used as Biomarkers to Demonstrate Genomic Heterogeneity in Primary Prostate Cancer.

Christian Arstad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.